Angiex Inc.

📍 Cambridge, United States🗓 Founded 2015👥 10 employees💰 Last funded 2024
Biotechnology Research🌐 angiex.com
Website LinkedIn
Angiex Inc. is a privately held biotech startup whose mission is to exploit newly discovered biological transport mechanisms to make drugs with revolutionary power over cancer. Based in Cambridge, Mass., Angiex was founded by a scientific team of leading experts in angiogenesis, vascular biology, and oncology. The company is developing a novel portfolio of Nuclear-Delivered Antibody-Drug Conjugates™ (ND-ADCs) that release therapeutic payloads directly into the nucleus or cytosol, where the site of payload action is located.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2015
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Germany
1
Frequently asked questions
Who invested in Angiex Inc.?
Angiex Inc. has 2 investors on record on gritt.io and 2 late-stage investors.
When did Angiex Inc. last raise funding?
The most recent investment in Angiex Inc. recorded on gritt.io was in 2024.
When was Angiex Inc. founded?
Angiex Inc. was founded in 2015.
What industry is Angiex Inc. in?
Angiex Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Angiex Inc. based?
Angiex Inc. is headquartered in Cambridge, United States.